Rosuvastatin
This drug is missing the following documents, can you help us by contributing something?
- On this page:
- Oppositions
Oppositions
Information related to relevant oppositions from around the world.
Patent Oppositions
The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.
Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.
| Country | Date | Who Filed | Opposition type | Opposition status | Patent type | Related patent application | More info |
|---|---|---|---|---|---|---|---|
| Argentina | 25-11-2002 | CILFA | Pre-Grant | Unknown | Other | P000100408 | View/Comment |
| Argentina | 19-12-2002 | CILFA | Pre-Grant | Unknown | Salts and Others | P000104057 | View/Comment |
| Argentina | 30-01-2003 | CILFA | Pre-Grant | Formulations | P000104058 | View/Comment |
Is something missing? Help us by contributing missing data: Contribute
Prior Art
This table lists related prior art used if a patent opposition has been filed on one or more of the patents.
| Title | Author | Name of publication | Publishing date | Related to | Related patent application | More info |
|---|---|---|---|---|---|---|
| EP0521471 | SHIONOGI & CO [JP] | European Patent Office | 07-01-1993 | Novelty | P000100408 | View/Comment |
| Synthesis and biological activity of methanesulphonamide pyrimidine and N-methanesulphonyl pyrrole-sustituted 3,5-dihydroxy-6-heptanoates, a novel series of HMG-CoA reductasa inhibitors | Masamichi Watanabe et al | BIOORGANIC. MED. CHEM. Vol. 5, Nº2, pages 473-474. | 01-01-1997 | Novelty | P000100408 | |
| ZD-4522 ; Hypolipidemic HMG-CoA reductasa inhibitor | GRAUL,A et al | DRUG of the FUTURE vol. 24, nº5, pages 511-513 | 01-01-1999 | Novelty | P000100408, P000104057, P000104058 | |
| The role of HMG-CoA reductasa inhibitors in the treatment of Hyperlipidemia: a review of fluvastatin | DESLYPERE JEAN PAUL | CURRENT THERAPEUTIC RESEARCH VOL. 56, issue 2, pages 111-128 | 01-02-1995 | Inventive Step | P000100408 | |
| Non-lipid-related effects of HMG-CoA reductase inhibitors | CORSINI, A et al | ATHEROSCLEROSIS vol.115, page S136. | 01-06-1995 | Inventive Step | P000100408 | |
| Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity | Pazzucconi, F et al | Atherosclerosis vol. 117, issue 2, pages 189-198 | 01-10-1995 | Inventive Step | P000100408 | |
| WO9723200 | KOWA CO [JP]; NISSAN CHEMICAL IND LTD and others | PCT | 03-07-1997 | Inventive Step | P000104057, P000104058 | View/Comment |
| GB2262229 | SANDOZ LTD [CH] | UK Patent Office | 16-06-1993 | Inventive Step | P000104057, P000104058 | View/Comment |
Is something missing? Help us by contributing missing data: Contribute